Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
EmailIphone Application    Posted: 12th August 2024
If you would like to forward this story on to a friend, simply fill in the form below and click send.
Your friend's email:
Your email:
Your name:
 
 
Send Cancel

EAE vaccine supply issues set to continue
“As a responsible provider, we are actively addressing these issues to minimise the impact on customers” – Roy Geary.
Vaccine won’t be available until October at the earliest.

The Cevac Chlamydia vaccine for enzootic abortion of ewes (EAE) will not be available in September as anticipated, Ceva Animal Health has announced.

The delay to the delivery of the vaccine follows a gap in supply between June and August caused by a batch being out of specification. Ceva Animal Health submitted an Out of Specification request for the vaccine to be released, but the request was not successful.

The next batch may be available in October, but the manufacture has said there is no certainty that it will be.

Last year also saw supply issues with the vaccine, which were blamed on delays in the manufacturing and distribution process.

EAE is one of the most common infectious causes of abortion in ewes. It is estimated to cost the UK sheep industry up to £20 million a year.

Ceva Animal Health has said that it deeply regrets any inconvenience caused to sheep farmers.

Roy Geary, vice-president for Northern Europe (including the UK) at Ceva Animal Health, said: “The manufacturing of vaccines is a complex process that involves stringent quality control measures and adherence to regulatory guidelines.

“There have been unforeseen manufacturing issues at our production facilities, which have temporarily affected the ability to meet the demands of the UK sheep market within the main seasonal vaccination period for EAE.

“As a responsible provider, we are actively addressing these issues to minimise the impact on customers.”

Ceva Animal Health is recommending that veterinary surgeons and farmers follow advice issued by the Sheep Veterinary Society and Sheep Antibiotic Guardian Group which can accessed here.

Image © Shutterstock

Become a member or log in to add this story to your CPD history

Practices urged to audit neutering data

News Story 1
 RCVS Knowledge has called on vet practices to audit their post-operative neutering outcomes.

It follows the release of the 2024 NASAN benchmarking report, which collates data from neutering procedures performed on dogs, cats and rabbits.

The benchmarking report enables practices in the UK and Ireland to compare their post-operative outcomes to the national average. This includes the rate of patients lost to follow-up, which in 2024 increased to 23 per cent.

Anyone from the practice can submit the data using a free template. The deadline for next report is February 2026.

Visit the RCVS Knowledge website to complete an audit. 

Click here for more...
News Shorts
UK's BSE risk status downgraded

The WOAH has downgraded the UK's international risk status for BSE to 'negligible'.

Defra says that the UK's improved risk status recognises the reputation for having the highest standards for biosecurity. It adds that it demonstrates decades of rigorous animal control.

Outbreaks of Bovine Spongiform Encephalopathy, also known as mad cow disease, have previously resulted in bans on Britain's beef exports.

The UK's new status could lead to expanded trade and better confidence in British beef.

Christine Middlemiss, the UK's chief veterinary officer, said: "WOAH's recognition of the UK as negligible risk for BSE is a significant milestone and is a testament to the UK's strong biosecurity measures and the hard work and vigilance of farmers and livestock keepers across the country who have all played their part in managing the spread of this disease.